Tivic Health Systems

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Hayward, CA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Tivic Health Systems reports revenue growth and strategic advancements in Q1 2024

Tivic Health Systems showcased revenue growth and strategic initiatives in their Q1 2024 earnings call, emphasizing progress in bioelectronic medicine and clinical studies.
While facing challenges in managing a net loss and optimizing sales dynamics, the company's strengths lie in fiscal responsibility, product innovation, and market expansion.
Opportunities abound for Tivic Health to capitalize on their VNS program success, ClearUp product momentum, and strategic funding for future growth and value creation.
By balancing financial discipline with innovation, Tivic Health aims to navigate challenges, leverage strengths, and seize opportunities for sustainable growth and market leadership.

Tivic Health Systems advances VNS technology amidst financial challenges

Tivic Health Systems is making strides in VNS technology development and clinical research, despite facing financial and compliance challenges. With a strong patent portfolio and a focus on innovation, the company is well-positioned to capitalize on emerging opportunities in the medical device market.

Tivic Health Systems navigates challenges, eyes growth in VNS market

Tivic Health Systems faces financial challenges but shows resilience through strategic focus on profitability, innovation, and operational efficiency.
The company's progress in the VNS program and market assessment efforts position it well for future growth and market expansion opportunities.
With a new CFO onboard and a proactive approach to addressing product challenges, Tivic Health is poised to navigate challenges and capitalize on growth prospects.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Fremont, CA.

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health's ClearUP named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine.

Tivic Health's ClearUP Named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health (TIVC) was one of two companies featured in the ABC News story “New Bioelectronic Technologies Could Signal the Future of Medicine.”

Tivic Featured in ABC News Report: “New Bioelectronic Technologies Could Signal the Future of Medicine”

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health announces trial with research hospital to investigate bioelectronic therapeutic device as alternative to opioids after sinus surgeries.

Tivic Health Collaborates With Leading Medical Research Hospital on First Controlled Trial to Extend Tivic's Bioelectronic Platform

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health (Nasdaq: TIVC) names Mindgruve as its digital marketing agency of record.

Tivic Health Names Mindgruve Digital Marketing Agency of Record

Bluejay Diagnostics

 Orbital Energy Group, Inc.

Reliance Global Group

The stock market is down today but these penny stocks are rallying. The post 4 Top Penny Stocks To Watch With The Stock Market Down Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Penny Stocks To Watch With The Stock Market Down Today

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health named to Fast Company's Next Big Things in Tech. CEO Jennifer Ernst receives Inc's 2021 Female Founders 100 award.

Tivic Health Named to Fast Company's Inaugural Next Big Things in Tech

Sphere 3D

Biofrontera

3 penny stocks with low floats to watch as shares of ENSC stock skyrocket. The post 3 Low Float Penny Stocks To Watch After ENSC Stock Soared appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Low Float Penny Stocks To Watch After ENSC Stock Soared

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health Systems, Inc. (Nasdaq: TIVC), a commercial-phase bioelectronic medicine company, today announced that CEO Jennifer Ernst will present a corporate overview at the Sidoti Micro Cap Conference taking place virtually, December 8-9, 2021. Ms. Ernst is scheduled to discuss the rapidly growing field of bioelectronic medicine and will participate in one-on-one meetings with investors during the event. Her virtual presentation will take place: Sidoti Micro Ca

Tivic Health CEO Jennifer Ernst to Speak at Sidoti Micro Cap Virtual Conference on December 8

Amplify Energy Corp.

Crescent Point Energy

InMed Pharmaceuticals

Vallon Pharmaceuticals

Are these on your list of penny stocks right now? The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 5 To Watch Before Next Week

MENLO PARK, Calif., Nov. 15, 2021 /PRNewswire/ -- Tivic Health Systems, Inc. (Nasdaq: TIVC) ("Tivic" or the "Company"), a commercial-phase bioelectronic medicine company, today announced the closing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share for gross proceeds of $15,000,000 before deducting underwriting discounts and offering expenses.

Tivic Health Systems, Inc. Announces Closing of Initial Public Offering

MENLO PARK, Calif., Nov. 10, 2021 /PRNewswire/ -- Tivic Health Systems, Inc. (Nasdaq: TIVC) ("Tivic" or the "Company"), a commercial-phase bioelectronic medicine company, today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $15,000,000, before deducting underwriting discounts and offering expenses.

Tivic Health Systems, Inc. Announces Pricing of Initial Public Offering

News for Tivic Health Systems Stock (TIVC)